(Q44437969)

3 December 2017

title

Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients (English)

1 reference

3 December 2017

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00233-1

1 January 2024

author name string

J. D. Morrisett

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742487

1 January 2024

G. Abdel-Fattah

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742487

1 January 2024

B. D. Kahan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742487

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0041134503002331?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00233-1

https://api.elsevier.com/content/article/PII:S0041134503002331?httpAccept=text/plain

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00233-1

Transplantation Proceedings

1 January 2024

published in

1 reference

3 December 2017

volume

35

1 reference

3 December 2017

issue

3 Suppl

1 reference

3 December 2017

page(s)

143S-150S

1 reference

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Sirolimus: a potent new immunosuppressant for liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Pediatric utilization of rapamycin for severe cardiac allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Rapamycin inhibits vascular smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Hypertriglyceridemia in renal transplant recipients treated with sirolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Lipoprotein lipase: some effects of activator proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Rapamycin: personal algorithms for use based on 250 treated renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

Evaluating atherosclerotic lesions by magnetic resonance imaging: from dimensional to compositional quantitation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900233-1

7 January 2021

American Journal of Physiology

22

265

814

Hellerstein

1993

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00233-1

1 January 2024

Identifiers

1 reference

3 December 2017

1 reference